Marinus Pharmaceuticals Statistics
Total Valuation
RKT has a market cap or net worth of $31.07 billion. The enterprise value is $44.19 billion.
Important Dates
The next confirmed earnings date is Thursday, July 31, 2025, after market close.
Earnings Date | Jul 31, 2025 |
Ex-Dividend Date | Mar 20, 2025 |
Share Statistics
RKT has 2.10 billion shares outstanding. The number of shares has decreased by -92.76% in one year.
Current Share Class | 254.91M |
Shares Outstanding | 2.10B |
Shares Change (YoY) | -92.76% |
Shares Change (QoQ) | +1,274.14% |
Owned by Insiders (%) | 0.37% |
Owned by Institutions (%) | 7.87% |
Float | 246.97M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 39.96 |
PS Ratio | 0.41 |
Forward PS | 5.23 |
PB Ratio | 3.77 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 15,942.97 |
EV / Sales | 8.70 |
EV / EBITDA | 57.47 |
EV / EBIT | 67.35 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.05, with a Debt / Equity ratio of 1.72.
Current Ratio | 22.05 |
Quick Ratio | 2.59 |
Debt / Equity | 1.72 |
Debt / EBITDA | 17.33 |
Debt / FCF | n/a |
Interest Coverage | 1.36 |
Financial Efficiency
Return on equity (ROE) is 1.54% and return on invested capital (ROIC) is 1.85%.
Return on Equity (ROE) | 1.54% |
Return on Assets (ROA) | 1.73% |
Return on Invested Capital (ROIC) | 1.85% |
Return on Capital Employed (ROCE) | 2.67% |
Revenue Per Employee | $357,925 |
Profits Per Employee | $195 |
Employee Count | 14,200 |
Asset Turnover | 0.21 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, RKT has paid $13.91 million in taxes.
Income Tax | 13.91M |
Effective Tax Rate | 9.49% |
Stock Price Statistics
The stock price has decreased by -8.54% in the last 52 weeks. The beta is 2.29, so RKT's price volatility has been higher than the market average.
Beta (5Y) | 2.29 |
52-Week Price Change | -8.54% |
50-Day Moving Average | 13.85 |
200-Day Moving Average | 13.52 |
Relative Strength Index (RSI) | 53.46 |
Average Volume (20 Days) | 21,309,812 |
Short Selling Information
The latest short interest is 81.11 million, so 3.86% of the outstanding shares have been sold short.
Short Interest | 81.11M |
Short Previous Month | 65.47M |
Short % of Shares Out | 3.86% |
Short % of Float | 32.84% |
Short Ratio (days to cover) | 5.44 |
Income Statement
In the last 12 months, RKT had revenue of $5.08 billion and earned $2.77 million in profits.
Revenue | 5.08B |
Gross Profit | 5.08B |
Operating Income | 656.15M |
Pretax Income | 27.32M |
Net Income | 2.77M |
EBITDA | 768.96M |
EBIT | 656.15M |
Earnings Per Share (EPS) | -$2.54 |
Full Income Statement Balance Sheet
The company has $1.69 billion in cash and $14.80 billion in debt, giving a net cash position of -$13.11 billion or -$6.23 per share.
Cash & Cash Equivalents | 1.69B |
Total Debt | 14.80B |
Net Cash | -13.11B |
Net Cash Per Share | -$6.23 |
Equity (Book Value) | 8.58B |
Book Value Per Share | 3.89 |
Working Capital | 13.78B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$413.52 million and capital expenditures -$67.49 million, giving a free cash flow of -$481.01 million.
Operating Cash Flow | -413.52M |
Capital Expenditures | -67.49M |
Free Cash Flow | -481.01M |
FCF Per Share | -$0.23 |
Full Cash Flow Statement Margins
Gross margin is 100.00%, with operating and profit margins of 12.91% and 0.05%.
Gross Margin | 100.00% |
Operating Margin | 12.91% |
Pretax Margin | 2.88% |
Profit Margin | 0.05% |
EBITDA Margin | 15.13% |
EBIT Margin | 12.91% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $0.80, which amounts to a dividend yield of 5.42%.
Dividend Per Share | $0.80 |
Dividend Yield | 5.42% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 92.76% |
Shareholder Yield | 98.17% |
Earnings Yield | 0.01% |
FCF Yield | -1.55% |
Dividend Details Analyst Forecast
The average price target for RKT is $14.19, which is -3.93% lower than the current price. The consensus rating is "Hold".
Price Target | $14.19 |
Price Target Difference | -3.93% |
Analyst Consensus | Hold |
Analyst Count | 13 |
Revenue Growth Forecast (5Y) | 13.08% |
EPS Growth Forecast (5Y) | 44.75% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
RKT has an Altman Z-Score of 1.03 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.03 |
Piotroski F-Score | 3 |